|
Helius Medical Technologies ، Inc. (HSDT) DCF تقييم
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Helius Medical Technologies, Inc. (HSDT) Bundle
هل تتطلع إلى تحديد القيمة الجوهرية لـ Helius Medical Technologies ، Inc.؟ يدمج حاسبة HSDT DCF الخاصة بنا البيانات الواقعية مع ميزات تخصيص شاملة ، مما يتيح لك تحسين توقعاتك وتعزيز اختيارات الاستثمار الخاصة بك.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.5 | .7 | .5 | .8 | .6 | .6 | .5 | .5 | .4 | .4 |
| Revenue Growth, % | 0 | -55.82 | -21.03 | 50.77 | -18.17 | -11.06 | -11.06 | -11.06 | -11.06 | -11.06 |
| EBITDA | -23.9 | -13.9 | -17.8 | -14.5 | -12.1 | -.6 | -.5 | -.5 | -.4 | -.4 |
| EBITDA, % | -1599.73 | -2103.48 | -3413.79 | -1842.95 | -1879.97 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .2 | .5 | .4 | .3 | .2 | .3 | .2 | .2 | .2 | .2 |
| Depreciation, % | 12.77 | 72.92 | 71.65 | 38.88 | 25.16 | 44.27 | 44.27 | 44.27 | 44.27 | 44.27 |
| EBIT | -24.1 | -14.4 | -18.2 | -14.8 | -12.3 | -.6 | -.5 | -.5 | -.4 | -.4 |
| EBIT, % | -1612.5 | -2176.4 | -3485.44 | -1881.83 | -1905.12 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 5.5 | 3.3 | 11.0 | 14.5 | 5.2 | .6 | .5 | .5 | .4 | .4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .6 | .2 | .3 | .3 | .6 | .3 | .3 | .2 | .2 | .2 |
| Account Receivables, % | 38.37 | 34.8 | 48.08 | 43.58 | 98.91 | 52.75 | 52.75 | 52.75 | 52.75 | 52.75 |
| Inventories | .6 | .4 | .5 | .6 | .8 | .4 | .4 | .3 | .3 | .3 |
| Inventories, % | 39.97 | 58.85 | 91.19 | 74.84 | 122.67 | 72.97 | 72.97 | 72.97 | 72.97 | 72.97 |
| Accounts Payable | 1.7 | .7 | 1.1 | .6 | .5 | .5 | .5 | .4 | .4 | .3 |
| Accounts Payable, % | 112.03 | 113.01 | 204.79 | 79.67 | 82.45 | 92.42 | 92.42 | 92.42 | 92.42 | 92.42 |
| Capital Expenditure | -.4 | -.1 | -.1 | .0 | .0 | -.1 | -.1 | .0 | .0 | .0 |
| Capital Expenditure, % | -23.6 | -10.59 | -10.73 | -2.16 | -4.5 | -10.32 | -10.32 | -10.32 | -10.32 | -10.32 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | 10.7 | -14.2 | -18.2 | -13.2 | -12.3 | -.4 | -.4 | -.4 | -.3 | -.3 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 11.0 | -14.2 | -17.7 | -13.6 | -12.7 | .5 | -.2 | -.2 | -.2 | -.1 |
| WACC, % | 9.29 | 9.95 | 9.96 | 9.89 | 9.96 | 9.81 | 9.81 | 9.81 | 9.81 | 9.81 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | -2 | |||||||||
| Present Terminal Value | -1 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | -5 | |||||||||
| Equity Value | 4 | |||||||||
| Diluted Shares Outstanding, MM | 1 | |||||||||
| Equity Value Per Share | 6.39 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real HSDT financials.
- Real-World Data: Historical data and forward-looking estimates (highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on Helius Medical Technologies’ valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Real-Life HSDT Data: Pre-filled with Helius Medical Technologies' historical financials and future growth projections.
- Fully Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax considerations, and capital investments.
- Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your specified inputs.
- Scenario Testing: Develop various forecasting scenarios to evaluate different valuation results.
- User-Friendly Design: Intuitive, organized, and crafted for both professionals and newcomers.
How It Works
- Download the Template: Get instant access to the Excel-based Helius Medical Technologies DCF Calculator.
- Input Your Assumptions: Adjust yellow-highlighted cells for growth rates, WACC, margins, and more.
- Instant Calculations: The model automatically updates Helius Medical Technologies’ intrinsic value.
- Test Scenarios: Simulate different assumptions to evaluate potential valuation changes.
- Analyze and Decide: Use the results to guide your investment or financial analysis.
Why Choose This Calculator?
- Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and consultants in the medical technology field.
- Accurate Data: Helius Medical Technologies' historical and projected financials are preloaded for precision.
- Scenario Analysis: Easily simulate various forecasts and assumptions to explore different outcomes.
- Comprehensive Outputs: Automatically calculates intrinsic value, NPV, and essential metrics for informed decision-making.
- User-Friendly: Step-by-step instructions ensure a smooth experience throughout the calculation process.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for assessing Helius Medical Technologies, Inc. (HSDT).
- Medical Device Teams: Evaluate valuation scenarios to inform product development strategies.
- Consultants and Advisors: Offer clients precise valuation insights for Helius Medical Technologies, Inc. (HSDT).
- Students and Educators: Utilize real-world data to practice and teach financial modeling in the healthcare sector.
- Tech and Medical Enthusiasts: Gain insights into how innovative medical technology companies like Helius Medical Technologies, Inc. (HSDT) are valued.
What the Template Contains
- Pre-Filled Data: Includes Helius Medical Technologies’ historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Helius Medical Technologies’ profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.